Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bullous dermatoses associated with systemic disease

S R Feldman1

  • 1Department of Dermatology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina.

Dermatologic Clinics
|July 1, 1993
PubMed
Summary

Non-immune, non-inherited bullous diseases are a diverse group. Classification by histopathology distinguishes similar-looking conditions like staphylococcal scalded skin syndrome and toxic epidermal necrolysis for better study and management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tofacitinib efficacy, patient-reported outcomes and safety in patients with psoriasis and a medical history of psoriatic arthritis: Pooled analysis of two Phase III studies.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Patient perspectives of atopic dermatitis: comparative analysis of terminology in social media and scientific literature, identified by a systematic literature review.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Secukinumab treatment and vaccination efficacy.

Clinical and experimental dermatology·2021
Same author

Pregnancy outcomes in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis receiving ixekizumab.

The Journal of dermatological treatment·2021
Same author

Assessing the relationship between topical corticosteroid phobia and susceptibility to misinformation in patients with atopic dermatitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Tildrakizumab: interpreting the data.

The British journal of dermatology·2021

Area of Science:

  • Dermatology
  • Pathology

Background:

  • Bullous diseases encompass a wide range of conditions affecting the skin.
  • Some bullous diseases are immune-mediated or inherited, while others are not.
  • A distinct group of bullous diseases lacks immune or inherited origins, presenting diagnostic challenges.

Purpose of the Study:

  • To classify bullous diseases that are neither immune-mediated nor inherited.
  • To establish clear distinctions between clinically similar entities within this group.
  • To emphasize the importance of accurate differentiation for research and patient care.

Main Methods:

  • Histopathologic characteristics were used as the primary classification criteria.
  • Comparative analysis was performed on diseases with overlapping clinical presentations.

Related Experiment Videos

  • Key differentiating features were identified for each entity.

    • Main Results:

    • A classification system for non-immune, non-inherited bullous diseases based on histopathology was proposed.
    • Distinct histopathologic features were identified to differentiate conditions such as staphylococcal scalded skin syndrome, toxic shock syndrome, erythema multiforme/toxic epidermal necrolysis, and acute graft-versus-host disease.
    • The classification aids in distinguishing entities with similar clinical appearances.

    Conclusions:

    • Histopathologic classification provides a robust framework for understanding heterogeneous bullous diseases.
    • Accurate differentiation of these conditions is crucial for advancing scientific study.
    • Effective management strategies depend on precise diagnosis of non-immune, non-inherited bullous disorders.